top of page

Search Results

319 items found for "Molecular targeting"

  • Interplay between G protein-coupled receptors and nanotechnology

    Although GPCRs are the molecular targets of the majority of marketed drugs, the poor pharmacokinetics of GPCRs on the surface of various types of cells, GPCR ligands can endow nanoparticles with active targeting It will provide a fundamental platform for developing powerful and safe GPCR-targeted drugs and nanoparticle STATEMENT OF SIGNIFICANCE: GPCRs as molecular targets for the majority of marketed drugs are naturally targeting , Nanoparticles , Signal transduction Source Contribute to the GPCR News Coming soon Become

  • Ep 71 with Dr. Jean Martin Beaulieu

    Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular target for drug development. In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia Beaulieu Lab has demonstrated that mood stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target

  • Interrogating Multiscale Receptors Functions in Space

    Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular target for drug development. In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia Beaulieu Lab has demonstrated that mood stabilizer drugs (e.g. lithium) used for bipolar disorder therapy target

  • RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway

    the PKA-Hippo signaling pathway Published date March 2, 2024 Abstract " Background: Novel therapeutic targets needed for treating drug-resistant non-small cell lung cancer (NSCLC) and overcoming drug resistance to molecular-targeted study aimed to identify the role of RGS20 in NSCLC prognosis and delineate associated cellular and molecular These insights support the role of RGS20 as a promising novel molecular marker and a target for future targeted therapies in lung cancer treatment."

  • Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking

    We retrieved targets for GG-derived compounds and GPCRs-related cancer from databases. Subsequently, we established a protein-protein interaction (PPI) network by mapping the shared targets We identified a total of 265 targets associated with GG-derived bioactive compounds for the treatment The PPI network analysis identified hub targets, including MAPK3, SRC, EGFR, STAT3, ESR1, MTOR, CCND1 , and PPARG, which demonstrate as treatment targets for GPCRs-related cancer using GG-derived compounds

  • G protein-coupled receptors: A target for microbial metabolites and a mechanistic link to microbiome-immune-brain interactions

    < GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptors: A target for microbial metabolites However, the underlying molecular mechanisms remain poorly understood. for deeper understanding of the inter-kingdom crosstalk at the molecular level. we elucidated their molecular interactions with specific human cell receptors, particularly expressed Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Chemoattractant receptor signaling in humoral immunity

    functional outcomes of β-arrestin-mediated signaling, ranging from receptor inactivation to effector molecule However, the molecular mechanisms by which individual GRKs are selectively targeted to GPCRs have been the context of humoral immunity and discuss the potential of the COMMD3/8 complex as a therapeutic target Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer

    < GPCR News < GPCRs in Oncology and Immunology Small-molecule targeting of GPCR-independent noncanonical Gαβγ) by G-protein-coupled receptors (GPCRs) is a quintessential mechanism of cell signaling widely targeted G-proteins can also be activated via GPCR-independent mechanisms that remain untapped as pharmacological targets these findings warrant the exploration of therapeutic modalities in G-protein signaling that go beyond targeting Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Molecular docking and dynamics simulation studies uncover the host-pathogen protein-protein interactions in Penaeus vannamei and Vibrio parahaemolyticus

    < GPCR News < GPCRs in Oncology and Immunology Molecular docking and dynamics simulation studies uncover interaction sites and the binding affinity between host and pathogen proteins were identified using molecular This finding illustrates the capability of computational approaches to search for molecular binding sites Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)

    < GPCR News < GPCRs in Oncology and Immunology Identification of Small-Molecule Antagonists Targeting The GHRHR has recently been highlighted as a promising drug target toward several types of cancer and However, no nonpeptide GHRHR-targeting compounds have yet been identified. We have utilized several computational tools to target GHRHR and identify potential small-molecule compounds Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy

    GPCRs in Oncology and Immunology Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted This review highlights the specific molecular actions and signaling pathways of olfactory receptors in The potential for precise tumor diagnosis and targeted therapy through therapeutic targeting of olfactory , Chun-Xia Zhang, Guo-Tai Wang Tags G Protein-coupled receptors , Olfactory receptors , Therapeutic targeting Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases

    < GPCR News < GPCRs in Oncology and Immunology CCR6 as a Potential Target for Therapeutic Antibodies To date, there are no drugs against CCR6 approved, and the development of small molecules against CCR6 This review highlights the potential as a therapeutic target of the CCR6 receptor in numerous diseases importance of the development of antibodies against CCR6 that could be a promising alternative to small molecules Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Ep 61 with About Dr. Marta Filizola

    the structure, dynamics, and function of important classes of membrane proteins and prominent drug targets uses several computational structural biology tools and rational drug design approaches, ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy perturbations Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics at the Molecular

  • Ep 150 with Dr GPCR Team

    in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors of South Florida, utilizing large-scale virtual drug screening to identify agonists and antagonists targeting With an immense passion for molecular pharmacology, his research focuses on elucidating the molecular basis of membrane protein signalling using quantitative assays and molecular modelling.

  • Metallo-protease Peptidase M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1

    Metallo-protease Peptidase M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1, a GPCR which is reported to be overexpressed in ovarian cancer cells, was identified as a target This established Peptidase M84 as a drug candidate for receptor mediated targeted-therapy of ovarian Gope, Rajdeep Das, Elizabeth Mahapatra, Saibal Saha, Ananda Pal, Parash Prasad, Amit Pal Tags Cancer , Molecular Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population

    and closely related thermosensory, systems in the vinegar fly Drosophila melanogaster to unravel the molecular each cell type could be characterized by a unique expression profile of ion channels, GPCR signaling molecules , synaptic vesicle cycle proteins, and cell adhesion molecules. Our findings provide valuable insights into the molecular basis of hygro- and thermosensation. Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Ep 85 with Nicholas Holliday

    Nick's interest in peptide messengers regulating appetite, metabolism, and the immune system, and the molecular Excellerate Bioscience as Chief Scientific Officer, a contract research organization specializing in molecular Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets , using its expertise in pharmacology to deliver high-quality target validation, lead optimization, and

  • G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis

    < GPCR News < GPCRs in Oncology and Immunology G Protein-coupled Receptor-mediated Membrane Targeting The study reveals a molecular mechanism of membrane targeting of PLCγ2 and the signaling pathways by Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Illuminating Functional Selectivity and Allosterism at GPCRs.

    an Associate Leader of the Experimental Therapeutics and Metabolism Program and the Director of the Molecular His expertise is in molecular pharmacology and his research program focuses on the molecular and cellular the allosteric, biased signalling regulation of GPCR and has contributed to the validation of small molecules

  • Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program HERE < Back to Full Agenda Session III Molecular Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets The NRS system has recently been validated in vivo by targeting the latrophilin-type aGPCR Cirl/ADGRL This tailored system aims to expedite the identification of drugs targeting the unique aGPCR receptor Our research aims to leverage this knowledge to identify novel pharmacological targets and contribute

  • Ep 143 with Dr Davide Calebiro

    Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research He studied Medicine in Milan and Stockholm, and obtained a PhD in Molecular Medicine and a Clinical Specialisation To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule on multiple panels and committees, including the ENDO Annual Meeting Steering Committee and the MRC Molecular

  • The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells

    The C-X-C motif chemokine receptor 4 (CXCR4) is a class A GPCR that is a promising target of anticancer Using a bimolecular fluorescence complementation (BiFC) assay, we identified the β2 adrenergic receptor To investigate the molecular scale details of CXCR4-β2AR interactions, we used a time-resolved fluorescence Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Ep 121 with Yao Lu (Jackie)

    involves the pharmacological and structural characterisation of novel putative antipsychotic small molecules Her research aims to provide a molecular explanation of small molecules for their pre-clinical efficacy

  • Ep 35 with Dr. Brian Arey

    He currently leads a team that provides a mechanistic understanding of small molecule drug candidates Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes.

  • Ep 34 with Dr. Brian Arey

    He currently leads a team that provides a mechanistic understanding of small molecule drug candidates Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes.

  • Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

    ), a G protein-coupled receptor (GPCR) expressed predominantly on eosinophils, is an important drug target This study constructed a nanogold receptor sensor using hCCR3 as the molecular recognition element and A molecular docking study was carried out to investigate how hCCR3 and its ligands work. Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma

    glioblastoma (GBM) and is involved in the mesenchymal transition, making it a promising therapeutic target GPR56 knockdown U373-GBM cells included in our above study along with detailed literature mining of the molecular The map incorporates more than 100 molecular entities including kinases, receptors, ion channels, and Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural and molecular

  • Distinct sub-cellular signal propagation as a component of functional selectivity

    :15 AM Abstract Coming Soon About Michel Bouvier "Michel Bouvier is a professor of Biochemistry and Molecular Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. signaling and GPCRs and made seminal contributions to our understanding of this major class of drug targets Scholar Pubmed ResearchGate Twitter LinkedIn Universite de Montreal- Department of Biochemistry and Molecular

bottom of page